Evidence map›Paper›PMID 34603825›Full record

ArticleScience China materials2022

Accelerated antibacterial red-carbon dots with photodynamic therapy against multidrug-resistant

Weijian Liu, Hua Gu, Bei Ran, Wenkai Liu, Wen Sun, Dongping Wang, Jianjun Du, Jiangli Fan, Xiaojun Peng

Open access · bronzeAbstract read
In one paragraph

Article in Science China materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review of Antimicrobial Properties of Carbon Nanomaterials.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Carbon Dots in Photodynamic/Photothermal Antimicrobial Therapy.Nanomaterials (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Carbon Dots for Killing Microorganisms: An Update since 2019.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Weijian LiuState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Hua GuState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Bei RanState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Wenkai LiuState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Wen SunState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Dongping WangState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Jianjun DuState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Jiangli FanState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Xiaojun PengState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024 China.
Dalian University · CNDalian University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of antibiotic resistance in bacteria is a major public-health issue. Synthesis of efficient antibiotic-free material is very important for fighting bacterial infection-related diseases. Herein, red-carbon dots (R-CDs) with a broad range of spectral absorption (350-700 nm) from organic bactericides or intermediates were synthesized through a solvothermal route. The prepared R-CDs not only had intrinsic antibacterial activities, but also could kill multidrug-resistant bacteria (multidrug-resistant Electronic Supplementary Material: Supplementary material is available for this article at 10.1007/s40843-021-1770-0 and is accessible for authorized users.

Indexed as

antibiotic-free materialscarbon dotsintrinsic antibacterial activitiesMRAB biofilm eradication

Identifiers

PMID34603825
PMCPMC8477720
OpenAlexW3202044742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.